Within the Council’s purview are (1) the benefits and risks of drug products, (2) evidence-based use of medicines, (3) the application of drug information in practice, and (4) related matters.
2026-2027 Term
| Name | Position | State |
| Sarah Gaffney | Chair | Virginia |
| Lance Ray | Vice Chair | Colorado |
| Lynda Eckhardt | Member | Kentucky |
| Kellie Goodlet | Member | Arizona |
| Kristi Kelley | Member | Alabama |
| Megan Musselman | Member | Missouri |
| Rachel Meyers | Member | New Jersey |
| Chris Oswald | Member | Indiana |
| Hai Tran | Member | California |
| Stephanie Weightman | Member | Tennessee |
| Kit Wong | Member | Federal Service |
| Jacqueline Jones | Technician | North Carolina |
| Alexis Culver | Student | Tennessee |
| Marie Chisholm-Burns | Board Liaison | Oregon |
| Vicki Basalyga | Secretary | Maryland |
